RANKL produced by tumor cells stimulates osteoclast precursor cells to differentiate osteoclasts [28, 29], which thereby activates osteoclasts, further providing a suitable bone microenvironment for tumor growth [30, 31]. The gene discussed is TNFSF11; the disease is neoplasm.